These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 11319763)
21. Histone deacetylase inhibitors as potential anti-skin cancer agents. Saunders N; Dicker A; Popa C; Jones S; Dahler A Cancer Res; 1999 Jan; 59(2):399-404. PubMed ID: 9927053 [TBL] [Abstract][Full Text] [Related]
22. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene]. Shen WJ; Dai DQ; Teng Y; Liu J Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115 [TBL] [Abstract][Full Text] [Related]
23. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]. Song Y; Kong BH; Liu PS; Ma DX; Jiang S Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708 [TBL] [Abstract][Full Text] [Related]
24. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Zhang RG; Zhang RP; Wang XW; Xie H Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411 [TBL] [Abstract][Full Text] [Related]
25. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related]
26. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. Ishihara K; Hong J; Zee O; Ohuchi K Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580 [TBL] [Abstract][Full Text] [Related]
27. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides. Zhang RG; Wang XW; Yuan JH; Xie H Acta Pharmacol Sin; 2000 Aug; 21(8):742-6. PubMed ID: 11501185 [TBL] [Abstract][Full Text] [Related]
28. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells. Wang Y; Duan HG; Chen SM; Xiao BK; Cheng J; Tao ZZ J Laryngol Otol; 2007 May; 121(5):476-82. PubMed ID: 17156515 [TBL] [Abstract][Full Text] [Related]
29. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Sekhavat A; Sun JM; Davie JR Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533 [TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. Frønsdal K; Saatcioglu F Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells. Karasawa Y; Okisaka S Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778 [TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. Li GC; Zhang X; Pan TJ; Chen Z; Ye ZQ Int J Urol; 2006 May; 13(5):581-6. PubMed ID: 16771729 [TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822 [TBL] [Abstract][Full Text] [Related]
34. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Mariadason JM; Corner GA; Augenlicht LH Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808 [TBL] [Abstract][Full Text] [Related]
35. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
36. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. Lea MA; Tulsyan N Anticancer Res; 1995; 15(3):879-83. PubMed ID: 7645975 [TBL] [Abstract][Full Text] [Related]
37. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age. Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955 [TBL] [Abstract][Full Text] [Related]
38. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Louis M; Rosato RR; Brault L; Osbild S; Battaglia E; Yang XH; Grant S; Bagrel D Int J Oncol; 2004 Dec; 25(6):1701-11. PubMed ID: 15547708 [TBL] [Abstract][Full Text] [Related]
39. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057 [TBL] [Abstract][Full Text] [Related]
40. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3]. Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]